PPARGC1A and atrial fibrillation: Metformin activated AMPK and Src kinase and normalized connexin expression, reducing pacing-induced AF effects and preventing atrial remodeling by activating the AMPK/PGC-1/peroxisome proliferator-activated receptor (PPAR)-pathway.